Publication

Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Reshma Jagsi, University of MichiganKevin C. Ward, Emory UniversityPaul Abrahamse, University of MichiganLauren P. Wallner, University of MichiganAllison W. Kurian, Stanford UniversityAnn S. Hamilton, University of Southern CaliforniaSteven J. Katz, University of MichiganSarah T. Hawley, University of Michigan
Language
  • English
Date
  • 2018-09-15
Publisher
  • Wiley: 12 months
Publication Version
Copyright Statement
  • © 2018 American Cancer Society
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0008-543X
Volume
  • 124
Issue
  • 18
Start Page
  • 3668
End Page
  • 3676
Grant/Funding Information
  • Cancer incidence data collection was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP003862–04/DP003862; the NCI’s Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California; contract HHSN261201000035C awarded to the University of Southern California; and contract HHSN261201000034C awarded to the Public Health Institute.
  • Funded by grant P01CA163233 to the University of Michigan from the National Cancer Institute; and supported by the University of Michigan Cancer Center Biostatistics, Analytics and Bioinformatics shared resource (P30CA46592).
  • Cancer incidence data collection in Georgia was supported by contract HHSN261201300015I; Task Order HHSN26100006 from the NCI; and cooperative agreement 5NU58DP003875–04-00 from the CDC.
Supplemental Material (URL)
Abstract
  • BACKGROUND: Little is known regarding whether growing awareness of the financial toxicity of a cancer diagnosis and its treatment has increased clinician engagement or changed the needs of current patients. METHODS: The authors surveyed patients with early-stage breast cancer who were identified through population-based sampling from 2 Surveillance, Epidemiology, and End Results (SEER) regions and their physicians. The authors described responses from approximately 73% of surgeons (370 surgeons), 61% of medical oncologists (306 medical oncologists), 67% of radiation oncologists (169 radiation oncologists), and 68% of patients (2502 patients). RESULTS: Approximately one-half (50.9%) of responding medical oncologists reported that someone in their practice often or always discusses financial burden with patients, as did 15.6% of surgeons and 43.2% of radiation oncologists. Patients indicated that financial toxicity remains common: 21.5% of white patients and 22.5% of Asian patients had to cut down spending on food, as did 45.2% of black and 35.8% of Latina patients. Many patients desired to talk to providers about the financial impact of cancer (15.2% of whites, 31.1% of blacks, 30.3% of Latinas, and 25.4% of Asians). Unmet patient needs for engagement with physicians about financial concerns were common. Of 945 women who worried about finances, 679 (72.8%) indicated that physicians and their staff did not help. Of 523 women who desired to talk to providers regarding the impact of breast cancer on employment or finances, 283 (55.4%) reported no relevant discussion. CONCLUSIONS: Many patients report inadequate clinician engagement in the management of financial toxicity, even though many providers believe that they make services available. Clinician assessment and communication regarding financial toxicity must improve; cure at the cost of financial ruin is unacceptable.
Author Notes
  • Reshma Jagsi, 1500 East Medical Center Drive SPC 5010, Ann Arbor, MI 48109, Telephone (734)936-4300, Fax (734)763-7371, rjagsi@med.umich.edu.
Keywords
Research Categories
  • Health Sciences, Oncology
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items